The RP11-295G20.2/PTEN axis promotes the growth of HCC cells, and RP11-295G20.2 could be a biological marker for HCC prognosis and might provide a therapeutic target for HCC treatment, especially in patients with PTEN protein loss. The gene discussed is PTEN; the disease is hepatocellular carcinoma.